Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Harnessing type I CRISPR-Cas systems for genome engineering in human cells.

Cameron P, Coons MM, Klompe SE, Lied AM, Smith SC, Vidal B, Donohoue PD, Rotstein T, Kohrs BW, Nyer DB, Kennedy R, Banh LM, Williams C, Toh MS, Irby MJ, Edwards LS, Lin CH, Owen ALG, K√ľnne T, van der Oost J, Brouns SJJ, Slorach EM, Fuller CK, Gradia S, Kanner SB, May AP, Sternberg SH.

Nat Biotechnol. 2019 Dec;37(12):1471-1477. doi: 10.1038/s41587-019-0310-0. Epub 2019 Nov 18.

PMID:
31740839
2.

The synthetic histone-binding regulator protein PcTF activates interferon genes in breast cancer cells.

Olney KC, Nyer DB, Vargas DA, Wilson Sayres MA, Haynes KA.

BMC Syst Biol. 2018 Sep 25;12(1):83. doi: 10.1186/s12918-018-0608-4.

3.

Erratum: Regulation of cancer epigenomes with a histonebinding synthetic transcription factor.

Nyer DB, Daer RM, Vargas D, Hom C, Haynes KA.

NPJ Genom Med. 2017 Sep 5;2:27. doi: 10.1038/s41525-017-0029-0. eCollection 2017.

4.

Regulation of cancer epigenomes with a histone-binding synthetic transcription factor.

Nyer DB, Daer RM, Vargas D, Hom C, Haynes KA.

NPJ Genom Med. 2017;2. pii: 1. doi: 10.1038/s41525-016-0002-3. Epub 2017 Jan 9. Erratum in: NPJ Genom Med. 2017 Sep 5;2:27.

Supplemental Content

Support Center